Ludmil K Manov, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 21 N 490 W, American Fork, UT 84003 Phone: 801-642-2396 Fax: 801-642-2496 |
Dr. Thu A Nguyen, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S, Suite 161, American Fork, UT 84003 Phone: 801-492-5992 Fax: 801-812-5439 |
Christopher Jay Reynolds, MD Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 N 1100 E, American Fork, UT 84003 Phone: 801-763-0901 Fax: 801-763-0903 |
Dr. Mohammad Entezari Taher, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 212 S 1100 E, American Fork, UT 84003 Phone: 801-763-0901 Fax: 801-763-0903 |
News Archive
New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.
Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.
Novartis Pharmaceuticals Corporation has been named the top company for diversity for the second year in a row on the annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2015 Top 50 Companies for Diversity on April 23 at an awards ceremony in New York, NY.
"On Friday August 10, the U.S. Department of State and [USAID] released the first ever U.S. Strategy to Prevent and Respond to Gender-based Violence Globally, including their implementation plans," Melanne Verveer, ambassador-at-large for global women's issues, writes in the department's "Dipnote" blog.
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
› Verified 6 days ago